Cabrera, M. C., Díaz-Cruz, E. S., Kallakury, B. V. S., Pishvaian, M. J., Grubbs, C. J., Muccio, D. D., & Furth, P. A. (2012). The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the Cyclin-CDK-Rb pathway.

Cabrera, M. Carla, Edgar S. Díaz-Cruz, Bhaskar V. S. Kallakury, Michael J. Pishvaian, Clinton J. Grubbs, Donald D. Muccio, and Priscilla A. Furth. The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated With Abnormal Activation of the Cyclin-CDK-Rb Pathway. 2012.

Cabrera, M. Carla, et al. The CDK4/6 Inhibitor PD0332991 Reverses Epithelial Dysplasia Associated With Abnormal Activation of the Cyclin-CDK-Rb Pathway. 2012.